Advertisement
Canadian Journal of Cardiology
Case Report| Volume 35, ISSUE 10, P1419.e17-1419.e20, October 2019

To Turn Over Rocks for Transcatheter Aortic Valve Replacement: Closure Time With Adenosine Diphosphate to Support Decisions in a Complex Transcatheter Aortic Valve-in-Valve Procedure

      Abstract

      We report a patient with severe aortic stenosis with an extremely high calcium score who underwent a transfemoral transcatheter aortic valve replacement with an Evolut R (Medtronic, Minneapolis, MN) and needed a valve-in-valve approach with a SAPIEN 3 (Edwards Lifesciences, Irvine, CA) to treat significant paravalvular leak. Interestingly, the closure time with adenosine diphosphate, assessed using the Platelet Function Analyzer 100 (Siemens Healthcare Diagnostics, Los Angeles, CA), measured after each important step of this complex procedure, correlated very well with the severity of the paravalvular leak.

      Résumé

      Nous rapportons le cas d’un patient présentant une sténose aortique grave et un taux extrêmement élevé de calcium, qui a subi un remplacement valvulaire aortique par cathéter par voie transfémorale au moyen du système Evolut R (Medtronic, Minneapolis, Minnesota) et qui a nécessité l’installation d’une valve SAPIEN 3 (Edwards Lifesciences, Irvine, Californie) dans la valve déjà en place pour traiter une importante fuite paravalvulaire. Fait intéressant, une étroite corrélation a été observée entre la gravité de la fuite paravalvulaire et le temps de fermeture avec l’adénosine-diphosphate, évaluée à l’aide du dispositif Platelet Function Analyzer 100 (Siemens Healthcare Diagnostics, Los Angeles, Californie) et mesurée après chaque étape importante de cette intervention complexe.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Van Belle E.
        • Rauch A.
        • Vincent F.
        • et al.
        Von Willebrand factor multimers during transcatheter aortic-valve replacement.
        N Engl J Med. 2016; 375: 335-344
        • Clavel M.A.
        • Pibarot P.
        • Messika-Zeitoun D.
        • et al.
        Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study.
        J Am Coll Cardiol. 2014; 64: 1202-1213
        • Barbanti M.
        • Webb J.G.
        • Gilard M.
        • Capodanno D.
        • Tamburino C.
        Transcatheter aortic valve implantation in 2017: state of the art.
        EuroIntervention. 2017; 13: AA11-AA21